Network origin in Serguei Nabirotchkine first degree
Entity | Entity type | Industry | |
---|---|---|---|
44
| Public Company | Biotechnology | 44 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Serguei Nabirotchkine via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
AMGEN INC. | Pharmaceuticals: Major | Chief Administrative Officer | |
Centocor, Inc.
Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Medical Specialties | Director/Board Member Corporate Officer/Principal | |
ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
IPSEN | Pharmaceuticals: Major | Chairman | |
Thunderbird School of Global Management | College/University | Graduate Degree | |
Suraypharm SAS | Chairman | ||
SILENCE THERAPEUTICS PLC | Miscellaneous Commercial Services | Chief Executive Officer Director of Finance/CFO | |
Institute of Chartered Accountants in England & Wales
Institute of Chartered Accountants in England & Wales Miscellaneous Commercial ServicesCommercial Services The Institute of Chartered Accountants in England & Wales ensures that its members, students, and affiliates maintain the highest standards of professional competency and conduct to protect the public interest. The non-profit company is based in London, UK, and has subsidiaries in the United Kingdom. With over 150,000 members, the institute provides technical information, helplines, and communities to its members. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
University of Cambridge | College/University | Graduate Degree Doctorate Degree | |
VALERIO THERAPEUTICS | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
MITHRA PHARMACEUTICALS S.A. | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer | |
INSEAD | College/University | Masters Business Admin Undergraduate Degree | |
ZEALAND PHARMA A/S | Pharmaceuticals: Major | Chief Executive Officer | |
CELLECTIS S.A. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
NEOVACS | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director/Board Member Chief Executive Officer | |
ESSEC Business School | College/University | Corporate Officer/Principal | |
École des Hautes Études Commerciales de Paris | College/University | Masters Business Admin Graduate Degree Graduate Degree Masters Business Admin | |
ESCP Europe Campus Paris | College/University | Corporate Officer/Principal | |
Ecole Spéciale des Travaux Publics | College/University | Undergraduate Degree | |
Philipps University of Marburg | College/University | Doctorate Degree Doctorate Degree | |
Ecole Nationale d'Administration | College/University | Masters Business Admin Undergraduate Degree | |
European Federation of Pharmaceutical Industries & Assns
European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Miscellaneous Commercial Services | Director/Board Member | |
EOS IMAGING | Medical Specialties | Director of Finance/CFO Director of Finance/CFO | |
TXCELL | Miscellaneous Commercial Services | Director/Board Member | |
PX Therapeutics SA
PX Therapeutics SA Miscellaneous Commercial ServicesCommercial Services PX Therapeutics SA manufactures and develops recombinant proteins and monoclonal antibodies. Its services include protein engineering, optimization of drug candidates, humanization of antibodies, and production and release of GMP batches for clinical studies. The firm specializes in the field of in-vivo and in-vitro diagnostics, industrial enzymes, and ancillary products. The company was founded by Tristan Rousselle and Nicolas Mouz in November 2000 and is headquartered in Grenoble, France. | Miscellaneous Commercial Services | Director/Board Member | |
Critical Care Diagnostics, Inc.
Critical Care Diagnostics, Inc. Medical SpecialtiesHealth Technology Critical Care Diagnostics, Inc. develops diagnostic tools. The firm offers Presage, a laboratory assay employing ST2 for the diagnosis and prognosis of cardiovascular disease. It also offers Aspect-PLUS ST2 test, a cardiac biomarker testing product that aids clinicians in assessing risk, making treatment decisions, evaluating therapy effectiveness, and monitoring patient care. The company was founded by Sven M. Jacobson and David M. Geliebter in 2004 and is headquartered in San Diego, CA. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
Remedy Pharmaceuticals, Inc.
Remedy Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Remedy Pharmaceuticals, Inc. develops and commercializes pharmaceutical ingridients. It focuses on small molecule drugs for acute central nervous system disorders. The company was founded by David M. Geliebter and Sven M. Jacobson in 2004 and is headquartered in New York, NY. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
CARMAT | Medical Specialties | Founder Director/Board Member | |
DEINOVE | Biotechnology | Founder Director/Board Member | |
Weill Cornell Medical College | College/University | Doctorate Degree | |
European Biopharmaceutical Enterprises
European Biopharmaceutical Enterprises BiotechnologyHealth Technology European Biopharmaceutical Enterprises develops biological products. The private company is based in Brussels, Belgium. | Biotechnology | Corporate Officer/Principal Chairman | |
Ipsen Pharma SAS
Ipsen Pharma SAS Pharmaceuticals: MajorHealth Technology Ipsen Pharma SAS is a biopharmaceutical company that develops medicines in oncology, neuroscience and rare diseases. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France. | Pharmaceuticals: Major | Chief Executive Officer | |
ADVICENNE | Pharmaceuticals: Generic | Chairman | |
American Chamber of Commerce In Denmark
American Chamber of Commerce In Denmark Miscellaneous Commercial ServicesCommercial Services The American Chamber of Commerce in Denmark is an organization that provides news, events, membership forums, and resources related to business in Denmark. The American Chamber of Commerce in Denmark is based in Copenhagen, Denmark. The organization focuses on promoting transatlantic data flows and foreign direct investments. Recently, the Danish government announced that it will invest 143 billion kroner in defense over the next decade. The organization also holds more than 50 events a year, including seminars and workshops on topics such as workforce planning and Danish taxation for expats. | Miscellaneous Commercial Services | Director/Board Member | |
G5 | Chairman | ||
Harvard Business School | College/University | Masters Business Admin | |
Columbia University College of Physicians & Surgeons | College/University | Corporate Officer/Principal | |
ABIVAX | Pharmaceuticals: Other | Founder Chief Executive Officer | |
Société des Membres de la Légion d'Honneur | Director/Board Member | ||
AKARI THERAPEUTICS, PLC | Biotechnology | Chief Executive Officer | |
The Cass Foundation | Director/Board Member | ||
IDORSIA LTD | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Epics Therapeutics SA
Epics Therapeutics SA Miscellaneous Commercial ServicesCommercial Services EPICS Therapeutics SA engages in the development of therapeutic solutions for cancer. The company was founded by Jean Combalbert, Alain Parthoens and Francois Fuks on February 20, 2018 and is headquartered in Charleroi, Belgium. | Miscellaneous Commercial Services | Founder Director/Board Member | |
Silence Therapeutics GmbH
Silence Therapeutics GmbH BiotechnologyHealth Technology Part of Silence Therapeutics Plc, Silence Therapeutics GmbH is a German biotechnology company that develops RNAi-based drugs. The company is based in Berlin, Germany and was founded in 2014. | Biotechnology | Chief Executive Officer | |
Ixaka Ltd.
Ixaka Ltd. BiotechnologyHealth Technology Ixaka Ltd. engages in the development of advanced cell-based therapeutics for the treatment of critical limb ischemia. The company was founded by Gaby Salem and Vicente Saez Gonzalez in 2015 and is headquartered in London, the United Kingdom. | Biotechnology | Chairman Chief Tech/Sci/R&D Officer |
Statistics
International
France | 22 |
United States | 13 |
United Kingdom | 7 |
Belgium | 5 |
Switzerland | 3 |
Sectoral
Health Technology | 26 |
Consumer Services | 13 |
Commercial Services | 8 |
Finance | 2 |
Operational
Director/Board Member | 217 |
Chairman | 87 |
Corporate Officer/Principal | 61 |
Chief Executive Officer | 59 |
Founder | 51 |
Most connected contacts
Insiders | |
---|---|
Philippe Pouletty | 51 |
Hugo Brugière | 33 |
Philippe Chambon | 31 |
Marc M. P. de Garidel | 31 |
Pierre Bastid | 29 |
Michel de Rosen | 28 |
Lawrence Steinman | 26 |
James Kuo | 24 |
David Solomon | 22 |
David Stout | 19 |
Piers John Morgan | 18 |
Jacques Attali | 18 |
Lena Elisabeth Svanberg | 16 |
Nabil Sakkab | 14 |
René Goedkoop | 12 |
- Stock Market
- Insiders
- Serguei Nabirotchkine
- Company connections